Title: Ketamine’s potential as a rapid antidepressant was overplayed
year: 2015
Journal: BMJ
Volume: 351
Typeofarticle: 10.1136/bmj.h4467
Abstract: Bold claims for ketamine were made in a press release of a small weak study and repeated in a newspaper article, but Melvyn W B Zhang and Roger C M Ho say it is inappropriate for use in depressionIn April 2014 the Guardian newspaper reported on what it described as “the first UK study to give ketamine to severely depressed patients.”1 This is how the press release from Oxford University had referred to the research.The story quoted Rupert McShane, a consultant psychiatrist at Oxford University’s department of psychiatry and an author of the study report, claiming, “This really is dramatic for some people and it’s the sort of thing that really makes it worth doing psychiatry.“We’ve seen remarkable changes in people who’ve had severe depression for many years that no other treatment has touched.”The study in question, published in the Journal of Psychopharmacology, was a case series of 28 patients with mood disorders who continued to take other psychotropic drugs while they were given repeated doses of ketamine over six weeks. …
URL: http://www.bmj.com/content/351/bmj.h4467.abstract
URI: https://open-access.imh.com.sg/handle/123456789/4855
Appears in Collections:2015

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.